Holm-Jorgensen Rasmus
SEC CIK 1950496 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ACRV | Acrivon Therapeutics, Inc. | CFO | 26.1K | — | — | 8 | 2022-11-14 | 2025-02-14 |
Most active insiders at ACRV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Blume-Jensen Peter | Pres, CEO, Dir | $82.3K | $34.4K |
| 2 | Devroe Eric | COO | $17.2K | $1,214 |
| 3 | Levy Adam D. | CFO | $15.0K | $1,793 |
| 4 | Miller Mary | CLO | — | $1,380 |
| 5 | Gamelin Erick | Chief Development Off | — | $804.00 |
| 6 | Peterson Katharine | CAO | — | $203.01 |
| 7 | Levin Michaela | Chief Business Off | — | — |
| 8 | Palani Santhosh | Dir | — | — |
| 9 | Masson Kristina | EVP - Business Ops, Dir | — | — |
| 10 | DiRocco Derek | Dir | — | — |
Holm-Jorgensen Rasmus made no open-market trades at ACRV in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-19 | 2025-02-14 | ACRV | Acrivon Therapeutics, Inc. | Holm-Jorgensen Rasmus | CFO | F - Tax | $5.42 | -434 | 26.1K | -2% | -$2,352 | |
| 2024-11-18 | 2024-11-14 | ACRV | Acrivon Therapeutics, Inc. | Holm-Jorgensen Rasmus | CFO | F - Tax | $7.92 | -368 | 26.5K | -1% | -$2,915 | |
| 2024-08-16 | 2024-08-14 | ACRV | Acrivon Therapeutics, Inc. | Holm-Jorgensen Rasmus | CFO | F - Tax | $7.02 | -368 | 26.9K | -1% | -$2,583 | |
| 2024-05-16 | 2024-05-14 | ACRV | Acrivon Therapeutics, Inc. | Holm-Jorgensen Rasmus | CFO | F - Tax | $8.36 | -368 | 27.3K | -1% | -$3,076 | |
| 2024-02-16 | 2024-02-14 | ACRV | Acrivon Therapeutics, Inc. | Holm-Jorgensen Rasmus | CFO | F - Tax | $3.40 | -434 | 27.6K | -2% | -$1,476 | |
| 2023-11-16 | 2023-11-14 | ACRV | Acrivon Therapeutics, Inc. | Holm-Jorgensen Rasmus | CFO | F - Tax | $5.08 | -1,470 | 28.1K | -5% | -$7,468 | |
| D | 2023-06-20 | 2023-06-16 | ACRV | Acrivon Therapeutics, Inc. | Holm-Jorgensen Rasmus | CFO | M - OptEx | $3.63 | +9,500 | 29.5K | +47% | +$34.5K |
| D | 2022-11-16 | 2022-11-14 | ACRV | Acrivon Therapeutics, Inc. | Holm-Jorgensen Rasmus | CFO | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations